Keywords: Personalized medicines, Marketing strategies, Research focus, Creative financing, BioSquare
BioSquare meeting identifies future trends, including patient-centered therapy and end to the blockbuster model
Article | 12 February 2010
Pharmaceutical groups as well as biotechnology companies are calling for highly innovative technologies (nanotechnologies, medical devices, in-silico technologies, etc). This ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- Elan makes "transformational" acquisitions and a divestment
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- SciClone gains China rights to Zensun's Neucardin
